Table of Contents

company-logo

Lipum AB (publ), a biopharmaceutical company, engages in the discovery and development of treatment for chronic inflammatory diseases in Sweden. It is developing SOL-116, a humanized antibody that is in late preclinical phase for the treatment of pediatric rheumatism and rheumatoid arthritis diseases. Lipum AB (publ) has a collaboration with Pelago Bioscience AB to focus on drug target monitoring during clinical studies of the lead candidate SOL-116. The company was founded in 2010 and is headquartered in Umeå, Sweden.

Lipum Dividend Announcement

• Lipum does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Lipum dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Lipum Dividend History

Lipum Dividend Yield

Lipum current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Lipum stock? Use our calculator to estimate your expected dividend yield:

Lipum Financial Ratios

P/E ratio-9.08
PEG ratio-0.09
P/B ratio7.46
ROE-161.80%
Payout ratio0.00%
Current ratio3.97
Quick ratio7.16
Cash Ratio0.77

Lipum Dividend FAQ

Does Lipum stock pay dividends?
Lipum does not currently pay dividends to its shareholders.
Has Lipum ever paid a dividend?
No, Lipum has no a history of paying dividends to its shareholders. Lipum is not known for its dividend payments.
Why doesn't Lipum pay dividends?
There are several potential reasons why Lipum would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Lipum ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Lipum has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Lipum a dividend aristocrat?
Lipum is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Lipum a dividend king?
Lipum is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Lipum a dividend stock?
No, Lipum is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Lipum stocks?
To buy Lipum you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Lipum stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.